1. Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines
   Sandra Huguenin et al, 2004, Molecular Cancer Therapeutics CrossRef